Matches in SemOpenAlex for { <https://semopenalex.org/work/W2985945616> ?p ?o ?g. }
- W2985945616 endingPage "5567" @default.
- W2985945616 startingPage "5567" @default.
- W2985945616 abstract "Current therapies are insufficient for metastatic prostate cancer (PCa) in men and dogs. As human castrate-resistant PCa shares several characteristics with the canine disease, comparative evaluation of novel therapeutic agents is of considerable value for both species. Novel isoquinolinamine FX-9 exhibits antiproliferative activity in acute lymphoblastic leukemia cell lines but has not been tested yet on any solid neoplasia type. In this study, FX-9′s mediated effects were characterized on two human (PC-3, LNCaP) and two canine (CT1258, 0846) PCa cell lines, as well as benign solid tissue cells. FX-9 significantly inhibited cell viability and induced apoptosis with concentrations in the low micromolar range. Mediated effects were highly comparable between the PCa cell lines of both species, but less pronounced on non-malignant chondrocytes and fibroblasts. Interestingly, FX-9 exposure also leads to the formation and survival of enlarged multinucleated cells through mitotic slippage. Based on the results, FX-9 acts as an anti-mitotic agent with reduced cytotoxic activity in benign cells. The characterization of FX-9-induced effects on PCa cells provides a basis for in vivo studies with the potential of valuable transferable findings to the benefit of men and dogs." @default.
- W2985945616 created "2019-11-22" @default.
- W2985945616 creator A5005182277 @default.
- W2985945616 creator A5006621343 @default.
- W2985945616 creator A5037495290 @default.
- W2985945616 creator A5038666210 @default.
- W2985945616 creator A5071303964 @default.
- W2985945616 creator A5075822984 @default.
- W2985945616 creator A5077693928 @default.
- W2985945616 creator A5079524945 @default.
- W2985945616 creator A5080777876 @default.
- W2985945616 creator A5087351196 @default.
- W2985945616 date "2019-11-07" @default.
- W2985945616 modified "2023-09-26" @default.
- W2985945616 title "Isoquinolinamine FX-9 Exhibits Anti-Mitotic Activity in Human and Canine Prostate Carcinoma Cell Lines" @default.
- W2985945616 cites W1419228847 @default.
- W2985945616 cites W1495807367 @default.
- W2985945616 cites W1546243601 @default.
- W2985945616 cites W1558701786 @default.
- W2985945616 cites W1904433804 @default.
- W2985945616 cites W2016309093 @default.
- W2985945616 cites W2029576606 @default.
- W2985945616 cites W2040454516 @default.
- W2985945616 cites W2055047482 @default.
- W2985945616 cites W2057477877 @default.
- W2985945616 cites W2059161924 @default.
- W2985945616 cites W2071124948 @default.
- W2985945616 cites W2075069597 @default.
- W2985945616 cites W2081112565 @default.
- W2985945616 cites W2098625105 @default.
- W2985945616 cites W2108627173 @default.
- W2985945616 cites W2123690891 @default.
- W2985945616 cites W2140016888 @default.
- W2985945616 cites W2152812885 @default.
- W2985945616 cites W2163974192 @default.
- W2985945616 cites W2167827438 @default.
- W2985945616 cites W2319985878 @default.
- W2985945616 cites W2328135220 @default.
- W2985945616 cites W2337557746 @default.
- W2985945616 cites W2402889164 @default.
- W2985945616 cites W2414096785 @default.
- W2985945616 cites W2529521293 @default.
- W2985945616 cites W2531825284 @default.
- W2985945616 cites W2564241908 @default.
- W2985945616 cites W2734474559 @default.
- W2985945616 cites W2753327319 @default.
- W2985945616 cites W2781525129 @default.
- W2985945616 cites W2789309821 @default.
- W2985945616 cites W2793799366 @default.
- W2985945616 cites W2797645683 @default.
- W2985945616 cites W2805184593 @default.
- W2985945616 cites W2806931468 @default.
- W2985945616 cites W2889646458 @default.
- W2985945616 cites W2890156794 @default.
- W2985945616 cites W2906684347 @default.
- W2985945616 cites W2916882841 @default.
- W2985945616 cites W2936645220 @default.
- W2985945616 cites W2938741348 @default.
- W2985945616 cites W2966112499 @default.
- W2985945616 cites W2984785086 @default.
- W2985945616 cites W4256002464 @default.
- W2985945616 cites W4366445828 @default.
- W2985945616 cites W2193839702 @default.
- W2985945616 doi "https://doi.org/10.3390/ijms20225567" @default.
- W2985945616 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6888667" @default.
- W2985945616 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31703454" @default.
- W2985945616 hasPublicationYear "2019" @default.
- W2985945616 type Work @default.
- W2985945616 sameAs 2985945616 @default.
- W2985945616 citedByCount "4" @default.
- W2985945616 countsByYear W29859456162021 @default.
- W2985945616 countsByYear W29859456162022 @default.
- W2985945616 crossrefType "journal-article" @default.
- W2985945616 hasAuthorship W2985945616A5005182277 @default.
- W2985945616 hasAuthorship W2985945616A5006621343 @default.
- W2985945616 hasAuthorship W2985945616A5037495290 @default.
- W2985945616 hasAuthorship W2985945616A5038666210 @default.
- W2985945616 hasAuthorship W2985945616A5071303964 @default.
- W2985945616 hasAuthorship W2985945616A5075822984 @default.
- W2985945616 hasAuthorship W2985945616A5077693928 @default.
- W2985945616 hasAuthorship W2985945616A5079524945 @default.
- W2985945616 hasAuthorship W2985945616A5080777876 @default.
- W2985945616 hasAuthorship W2985945616A5087351196 @default.
- W2985945616 hasBestOaLocation W29859456161 @default.
- W2985945616 hasConcept C121608353 @default.
- W2985945616 hasConcept C126322002 @default.
- W2985945616 hasConcept C142724271 @default.
- W2985945616 hasConcept C1491633281 @default.
- W2985945616 hasConcept C150903083 @default.
- W2985945616 hasConcept C154317977 @default.
- W2985945616 hasConcept C185592680 @default.
- W2985945616 hasConcept C190283241 @default.
- W2985945616 hasConcept C202751555 @default.
- W2985945616 hasConcept C207001950 @default.
- W2985945616 hasConcept C2779013556 @default.
- W2985945616 hasConcept C2779723316 @default.
- W2985945616 hasConcept C2780192828 @default.
- W2985945616 hasConcept C502942594 @default.